December 22, 2025

Indian company Shilpa will build two factories in the Krasnodar Territory for the production of dietary supplements and oncology drugs.

Pharma

The Indian pharmaceutical company Shilpa, one of the world's leading producers of drugs for treating oncological diseases, plans to build two facilities in the Krasnodar Territory. This was announced by the governor of the region, Veniamin Kondratyev, following a meeting with Ravindra Kumar, the head of Shilpa Medicare Limited's representative office in Russia and the CIS.

"They [the company] plan to build two factories in the region. They will start with a small production of bioactive supplements, and in a few years, they intend to begin creating a facility for producing essential oncology drugs. They will use their own advanced technologies and equipment. Eventually, the products are expected not only to meet the internal needs of the region but also to be exported," Kondratyev wrote in his Telegram channel.

The regional leader assured that local authorities are ready to "provide full support for the project and assist at all stages of its implementation."

Shilpa Medicare specializes in the development, manufacture, and sale of active pharmaceutical ingredients and finished drug formulations, primarily oncology drugs, on regulated markets worldwide, including the USA.

 

 

Source: GxPnews

Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

In today’s world, effective resource management is becoming an increasingly crucial aspect of successful business operations. This is especially true for industries where equipment plays a key role—such as pharmaceuticals, cosmetology, and the food industry.

02.10.2025
Pharma

A new granulation line has been launched at the ALIUM pharmaceutical site (Binnopharm Group) in Obolensk, Moscow region. The equipment is designed for loads of up to 150 kg per cycle and significantly raised the plant's productivity, which is already heading toward 70 million packs of medicines a year.

19.10.2026
Pharma

A new administrative and production-warehouse complex of the pharmaceutical enterprise Farmstandart-UfaVITA has been commissioned in the center of Ufa. Investment exceeded 10 billion rubles, and new production lines are designed to produce 75 million medicine packages per year.

06.10.2026
Pharma

A Russian drugmaker, with the support of integrator IST-PAK, deployed an Italian SIEMPHARMA SRL counting-filling line for packaging tablets and capsules into plastic jars. The project was delivered despite a constrained shop floor and a fixed budget.

02.10.2026
Pharma

Farmasyntez Group commissioned a new pharmaceutical enterprise in Ussuriysk (Primorsky Krai). The plant with a design capacity of 12 million medicine packages a year was implemented under the import substitution program Pharma-2030; 90% of manufactured items are on the VED list.

01.10.2026
Pharma

Argumentum Pharma is completing the equipping of its new pharmaceutical plant in Moscow region's Dubna SEZ: high-tech automated filling and packaging lines have already been installed. Total investment in the project is estimated at 2.5 billion rubles, with commissioning planned before the end of 2026.

29.09.2026
Pharma

The Russian pharmaceutical manufacturer PFK "Renewal", operating under the Renewal brand, has commissioned a new production facility for the production of vital and essential medicines (VED) in the Novosibirsk region. The area of the complex exceeds 18.1 thousand square meters, and the design capacity reaches 100 million packages of finished products annually.

23.09.2026
Pharma

"VERTEX" is completing the commissioning of a blister-cardboard line with double-sided aluminum packaging, unique for its capacities. The new machine will become the tenth blister line of the enterprise and will allow to produce about 260 thousand packages by the end of 2026.

21.09.2026
Pharma

""""On Moscow Industry Day, Sergei Sobyanin opened a new production complex "Generium-Next" (GC "Farmstandart") at the Alabushevo site. The company will produce genetically engineered drugs for orphan and socially significant diseases for 8.5 billion rubles.

18.09.2026
Pharma

""PSK Pharma" company has completed a major project to modernize the production site of capsules with powder for inhalation at its own enterprise in the "Dubna" special economic zone. Investments exceeded 1 billion rubles, which made it possible to double the capacity of the line — from 80 to 160 thousand capsules per hour — and purchase new analytical and tablet equipment.

17.09.2026
Pharma

PJSC "Biosynthesis", one of the largest pharmaceutical enterprises in the Penza region, is preparing to launch a reconstructed production site for tablet dosage forms. The volume of investments in the project is 350 million rubles, and the implementation will increase the production of drugs, including those included in the list of VED.

16.09.2026
Pharma

Pharmaceutical manufacturer "Nizhpharm" announced the launch of a new line of packaging and packaging of soft dosage forms. The volume of investments in the project amounted to 158 million rubles, the maximum speed of the equipment reaches 270 packages per minute, which will increase production by 50%.

15.09.2026